← back to search

Gang Liu

Université de Lorraine · FR
Area of research
Biomedical Engineering · Molecular Biology
Research interest
Research interests include Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery, and Advanced biosensing and bioanalysis techniques.
h-index
110
citations
48,374
works
1,367
NIH funding
primary concept
email

Recent publications

Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics
Bioactive Materials 2026cited by 5position: contributordoi
Molecular engineering organometallic sonosensitizer for enhanced sonodynamic therapy via promoting ER stress-mediated HIF-1α degradation and cGAS-STING pathway activation
Chinese Chemical Letters 2026cited by 3position: contributordoi
Micro-nanomaterials-engineered delivery systems for reshaping the tumor immune microenvironment in hepatocellular carcinoma
Chinese Chemical Letters 2026cited by 2position: contributordoi
Sonotheranostic nanosideromycin eradicates bacterial biofilm infections via ultrasound-detonated ROS generation and ferroptosis-like death.
2026cited by 1position: contributordoi
Hydrogel-based tumor embolization and synergistic therapeutic strategies
Bioactive Materials 2026cited by 1position: contributordoi
Hollow nanofactory with dotted interior surface produces potent hydroxyl radical to combat drug-resistant large tumors.
2026cited by 0position: contributordoi
A biomimetic nanodisc system selectively activates type I interferons by nonclassical STING pathway for cancer immunotherapy.
2026cited by 0position: contributordoi
Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway.
2026cited by 0position: contributordoi
Intravascular Ultrasound-Guided Local Theranostics Enables Precise Treatment of Atherosclerotic Plaques.
2026cited by 0position: contributordoi
CD38-Targeted Small-Molecule PET Radiotracer for Noninvasive Tumor Evaluation and Preliminary Therapy Monitoring in Multiple Myeloma.
2026cited by 0position: contributordoi
Engineering NIR-II carbon dots through aniline extension with graphene and nitrogen enrichment for hepatobiliary theranostics.
2026cited by 0position: contributordoi
Cold atmospheric plasma-engineered nanovaccine with spatiotemporal sequential immunization reprograms antitumor immunity.
2026cited by 0position: contributordoi
Regorafenib and R837 Nanoparticle-Stabilized Pickering Emulsions Overcome the Angiogenesis-Immune Tolerance Axis in Transarterial Chemoembolization
Biomaterials 2026cited by 0position: contributordoi
Unsupervised abdominal multimodal image registration based on modality and morphological alignment
Expert Systems with Applications 2026cited by 0position: contributordoi
Bispecific antibody vesicles: a multifunctional bioactive drug delivery platform for the treatment of Pseudomonas aeruginosa infection
Asian Journal of Pharmaceutical Sciences 2026cited by 0position: contributordoi
Cold atmospheric plasma redefining antiviral innovation for post-pandemic challenges
Chinese Chemical Letters 2026cited by 0position: contributordoi
Dual-mode hepatoprotective nanoplatform combines ROS scavenging and FGF21 activation for precision acute liver injury therapy
Acta Pharmaceutica Sinica B 2026cited by 0position: contributordoi
Nanotherapeutics for ocular posterior segment diseases therapy: Towards its advances and challenges
Chinese Chemical Letters 2026cited by 0position: contributordoi
Ultra-low-dose radioimmunotherapy improves prostate cancer treatment efficacy and safety
Chinese Chemical Letters 2026cited by 0position: contributordoi
Design of an Active Haptic Interface Using Proprioception Feedback for Continuous Endovascular Teleoperation
IEEE Robotics and Automation Letters 2026cited by 0position: contributordoi
Fluorescence excitation strategies driven by different energy sources: Mechanism, molecular/materials design, and cross-applications
Chinese Chemical Letters 2026cited by 0position: contributordoi
Fully active zinc nitroprusside nanomedicine transforms cisplatin into chemoimmunotherapeutic agent for robust hepatocellular carcinoma therapy
Cell Biomaterials 2026cited by 0position: contributordoi
Evolution of embolization microspheres from physical occlusion to theranostic modulation in hepatocellular carcinoma treatment
EngMedicine 2026cited by 0position: contributordoi
Precision nanomedicine for lung metastatic osteosarcoma: challenges, therapeutic strategies, and perspectives
Materials Today Bio 2026cited by 0position: contributordoi
DualVision: A comparative study of ultraviolet–near infrared imaging and deep neural networks for Epimedii Folium identification
Chinese Chemical Letters 2026cited by 0position: contributordoi
Lophatherum-Gracile driven near-infrared carbon dots inhibit ferroptosis and mitophagy to treat acute kidney injury
Chemical Engineering Journal 2025cited by 23position: contributordoi
Nanomaterial-enabled anti-biofilm strategies: new opportunities for treatment of bacterial infections.
2025cited by 15position: contributordoi
Evaluation of biological performance of 3D printed trabecular porous tantalum spine fusion cage in large animal models
Journal of Orthopaedic Translation 2025cited by 15position: middledoi
Next‐Generation Oral Ulcer Management: Integrating Cold Atmospheric Plasma (CAP) with Nanogel‐Based Pharmaceuticals for Inflammation Regulation
Advanced Healthcare Materials 2025cited by 12position: middledoi
Next-Generation Oral Ulcer Management: Integrating Cold Atmospheric Plasma (CAP) with Nanogel-Based Pharmaceuticals for Inflammation Regulation.
2025cited by 10position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 200 papers (2019–2026)Yang Zhang · Beihua University38 papers (2019–2026)Hongwei Cheng · Huaqiao University15 papers (2020–2026)Chengchao Chu · Zhejiang University13 papers (2019–2026)Chao Liu · Shenzhen University6 papers (2022–2026)Chengchao Chu · Xiamen University6 papers (2020–2025)Hongwei Cheng · Anhui Medical University6 papers (2021–2025)En Ren · Xiamen University6 papers (2019–2024)Xiaoyong Wang · Xiamen University5 papers (2020–2026)Jianzhong Zhang · Peking University5 papers (2022–2026)Ai-Zheng Chen · Huaqiao University5 papers (2020–2024)Xiaoyuan Chen · National University of Singapore5 papers (2019–2022)Yutian Xia · Xiamen University4 papers (2023–2024)Dong Li · Hoshi University4 papers (2021–2023)Lai Jiang · Hubei University4 papers (2021–2024)Peiyu Wang · State Key Laboratory of Food Science and Technology4 papers (2023–2026)Jiaxin Ma · Xiamen University4 papers (2022–2025)Syed Faheem Askari Rizvi · Xiamen University4 papers (2025–2025)Junqing Wang · Ministry of Education of the People's Republic of China4 papers (2019–2023)Ningshao Xia · Monash University4 papers (2019–2025)